Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2026-02-25 @ 3:35 AM
Study NCT ID:
NCT03969420
Status:
TERMINATED
Last Update Posted:
2023-11-09
First Post:
2019-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
Sponsor:
Sumitomo Pharma America, Inc.
Organization: